Physician profile
Robert Boada
NPI 1578527396
$3,275.68
in general payments reported to CMS, 2019-2025
9 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $829 · 2020: $102 · 2021: $117 · 2022: $685 · 2023: $910 · 2024: $250 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,542.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dutch Ophthalmic, USA | $708.47 | 2023-2025 | Eva, Combined Machine, Tissueblue |
| Regeneron Healthcare Solutions, INC. | $586.89 | 2019-2023 | Eylea Hd, Eylea |
| Genentech USA, INC. | $433.11 | 2022-2025 | Vabysmo |
| Bausch & Lomb Americas INC. | $415.84 | 2022 | |
| Alcon Puerto Rico INC | $403.32 | 2019-2025 | Unity, Clareon |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $321.10 | 2019-2020 | |
| Apellis Pharmaceuticals, INC. | $240.10 | 2023-2024 | Syfovre |
| Glaxosmithkline, LLC. | $97.09 | 2019 | |
| Carl Zeiss Meditec, INC. | $69.76 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Boada listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.